The global agentic AI in healthcare market, valued at USD 0.80 billion in 2025, is projected to reach USD 1.17 billion in 2026 and USD 32.76 billion by 2035, with a CAGR of 44.9% during the forecast period 2026 to 2035. Driven by the increasing demand, several market players are undertaking initiatives to agent AI that are more proactive and efficient. In order to leverage competitive edge, the market players are leveraging partnerships and collaborations. For instance, in October 2025, IBM (US)...

The generative AI in healthcare market, valued at USD 3.3 billion in 2025, is projected to reach USD 4.7 billion in 2026 and USD 39.8 billion by 2035, with a 26.7% CAGR during the forecast period 2026 to 2035. Implementing generative AI in pharma for administrative tasks can lead to substantial annual savings (of around $150 billion) across the healthcare sector. Furthermore, a study shows that it can reduce diagnostic errors by around 85% and reduce nursing overtime by 21%, translating into the...

AI governance market size is forecasted to reach USD 26.91 billion by 2035, growing at a 41.36% CAGR from USD 1.19 billion in 2026. These machine learning governance solutions address concerns related to the right to be informed and potential violations, striving to bridge the gap in technological advancement by enhancing transparency and ethical considerations. As the deployment of artificial intelligence expands across various sectors such as AI in healthcare, infrastructure, finance, educatio...

The global AI in drug manufacturing market is estimated to grow from USD 0.9 billion in 2025 to reach USD 1.2 billion in 2026 and USD 34.8 billion by 2040, representing a CAGR of 27.2% during the forecast period 2026 to 2040. In June 2025, Aizon entered into a partnership with Sequence aimed at delivering comprehensive, AI-powered solutions for the pharmaceutical industry. Based on the type of AI solution, the global market includes standard / off-the-shelf AI solutions and personalized AI solut...

Market players, such as Siemens Healthcare (Germany), GE Healthcare (US) and AliveCor (US) are undertaking strategic initiatives to strengthen their product portfolio. For instance, in January 2025, Philips (US) launched AI enabled CT 5300 at 23rd Asian Oceanian Congress of Radiology (ACOR) 2025. This revolutionary X-ray CT diagnosis system is equipped with advanced AI capabilities for diagnosis and screening diseases with higher accuracy. As more market players continue to innovate new AI techn...

With an increasing emphasis on omics for personalized drug creation and disease identification, resulting in a significant increase in the use of artificial intelligence (AI) in omics studies. The increased support of AI in the field provides significant opportunities for industry players to leverage collaborations and partnerships to drive innovations. For instance, in June 2025, BioAro (Canada) launched a groundbreaking PanOmiQ™ platform at the 2025 BIO International Convention in Boston. Th...

With increasing demand across healthcare and pharmaceutical industries, several market players are actively exploring new possibilities for innovations in this field. Market players, such as MGI Tech (China), Illumina (US), and NVIDIA (US) are leveraging partnerships for developing AI based digital genome technologies. For instance, in June 2025, MGI Tech (China) signed a strategic collaboration with GenePowerRx (India) to revolutionize the predictive healthcare and precision medicine landscape...

The global healthcare cloud computing market, valued at USD 62.92 billion in 2024, is projected to reach USD 74.24 billion in 2025 and USD 286.27 billion by 2035, representing a CAGR of 14.4% during the forecast period. Given the increasing initiatives and investment by industrial players, we believe that global healthcare cloud computing market is expected to grow at a substantial rate during the forecast period.

The causal AI market size is projected to grow from USD 63.37 million in 2025 to USD 1,628.43 million by 2035, representing a CAGR of 38.35%, during the forecast period till 2035. The market for causal AI is experiencing substantial growth due to several driving factors. The rise of virtual assistants and chatbots that can engage in natural language interactions has spurred demand for causal AI applications. Additionally, the decreasing costs associated with hardware, cloud computing, and storag...

The global healthcare predictive analytics market, valued at USD 18.55 billion in 2024, is projected to reach USD 23.10 billion in 2025 and USD 207.53 billion by 2035, representing a CAGR of 24.55% during the forecast period. Given the heightened demand for advanced analytics tools, several organizations have taken strategic initiatives to support the development of robust analytics software and services. For instance, in July 2024, the World Health Organization / Europe has launched a Strategi...

The global artificial intelligence (AI) in healthcare market size, valued at USD 22.61 billion in 2024, is expected to reach USD 35.71 billion in 2025 and USD 765.12 billion by 2035, representing a higher CAGR of 35.9% during the forecast period. Earlier in February 2024, All India Institute of Medical Sciences (AIIMS) Delhi, India has launched an AI system that was trained by utilizing a data set of 500,000 radiological and histopathological images taken from 1,500 patients of breast and ovaria...

The AI in medical imaging market size is projected to grow from $1.75 billion in 2024 to $8.56 billion by 2030, growing at a CAGR of 30% during the forecast period from 2024 to 2030. Notably, in situations characterized by low physician / pathologist to patient ratios, the conventional mode of operation is rendered inadequate. Experts have predicted a shortage of 10,000 to 40,000 physicians, by 2030, in the US alone. Over time, various industry stakeholders have designed proprietary deep learnin...